• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无淀粉样β沉积病例海马结构中早期阿尔茨海默病相关tau包涵体的序列和轨迹

Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits.

作者信息

Braak Heiko, Mayer Benjamin, Feldengut Simone, Schön Michael, Del Tredici Kelly

机构信息

Department of Neurology, Center for Biomedical Research, Clinical Neuroanatomy, University of Ulm, Helmholtzstrasse 8/1, 89081, Ulm, Germany.

Institute of Epidemiology and Medical Biometry, University of Ulm, 89075, Ulm, Germany.

出版信息

Acta Neuropathol. 2025 May 23;149(1):50. doi: 10.1007/s00401-025-02862-x.

DOI:10.1007/s00401-025-02862-x
PMID:40407905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12102137/
Abstract

Sporadic Alzheimer's disease (AD) involves specific neuronal types and progresses in a systematic manner, permitting subdivision into six neuropathological stages. Neurofibrillary tangle (NFT) stages I-III display abnormal tau inclusions confined to subcortical nuclei and temporal allocortical regions, frequently without amyloid β (Aβ) deposition. We previously suggested a sequence of neuronal involvement in AD that could proceed from entorhinal pre-α cells to hippocampal prosubicular pyramidal cells and the CA1/CA2 sectors, from there to the thorny excrescences on mossy cells in CA3/CA4, and, finally, from the mossy cells to dentate fascia (Fd) granular cells. Here, we aimed to see if associations existed between the early NFT stages I-III, when Aβ deposits are frequently absent, and the following four categories: (1) anatomical regions and abnormal morphological tau changes in region-specific layers, (2) nerve cell loss, (3) APOE genotype, and (4) the trajectory (directionality) of tau progression in the hippocampal formation. To do so, we examined the transentorhinal/entorhinal regions and hippocampal formation using AT8-immunohistochemistry in 100 µm sections from N = 308 brains with tau inclusions lacking Aβ deposits between NFT stages I and III (average age at death 66.7 years for females, 66.4 years for males). Our results indicated a significantly (p < 0.001) ordered progression of abnormal tau in a direction opposite to currently known unidirectional intrahippocampal connections, thereby indirectly supporting the idea of transneuronal abnormal tau spreading, i.e., anterogradely, through the hippocampal formation. Tau-related neuronal loss was also significant (p < 0.001 for the transentorhinal/entorhinal regions and for sectors CA1/CA2 and p = 0.003 for CA3/CA4/Fd). These findings challenge the amyloid cascade and the PART hypotheses, corroborating the concept that early AD-related tau inclusions and tau-related neuronal loss occur independently of Aβ deposition.

摘要

散发性阿尔茨海默病(AD)累及特定的神经元类型,并以一种系统性的方式进展,可细分为六个神经病理学阶段。神经原纤维缠结(NFT)的I-III期表现为异常的tau包涵体,局限于皮质下核团和颞叶原皮质区域,通常无淀粉样β蛋白(Aβ)沉积。我们之前提出了AD中神经元受累的顺序,可能从内嗅前α细胞发展到海马旁下托锥体细胞和CA1/CA2区,从那里到CA3/CA4区苔藓细胞上的棘状突起,最后从苔藓细胞到齿状回颗粒细胞。在此,我们旨在探究在Aβ沉积通常缺失的早期NFT的I-III期与以下四类情况之间是否存在关联:(1)解剖区域及区域特异性层中异常的形态学tau变化,(2)神经细胞丢失,(3)APOE基因型,以及(4)海马结构中tau进展的轨迹(方向性)。为此,我们使用AT8免疫组织化学方法,对来自N = 308例大脑的100μm切片中的跨内嗅/内嗅区域和海马结构进行了检查,这些大脑在NFT的I期和III期之间存在缺乏Aβ沉积的tau包涵体(女性平均死亡年龄66.7岁,男性平均死亡年龄66.4岁)。我们的结果表明,异常tau呈显著(p < 0.001)有序进展,其方向与目前已知的海马内单向连接方向相反,从而间接支持了跨神经元异常tau传播的观点,即通过海马结构顺行传播。tau相关的神经元丢失也很显著(跨内嗅/内嗅区域以及CA1/CA2区p < 0.001,CA3/CA4/齿状回p = 0.003)。这些发现对淀粉样蛋白级联假说和PART假说提出了挑战,证实了早期AD相关的tau包涵体和tau相关的神经元丢失独立于Aβ沉积而发生的概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/097069ab5f7b/401_2025_2862_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/001a88acc161/401_2025_2862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/e4993d45a700/401_2025_2862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/e78943d45336/401_2025_2862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/9038d1164e5f/401_2025_2862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/d3205b4f0a7c/401_2025_2862_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/caea7de55613/401_2025_2862_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/2ed3c8bbd938/401_2025_2862_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/9c969ae7c589/401_2025_2862_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/a6fe3d6d2371/401_2025_2862_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/a31447a93c13/401_2025_2862_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/3d05f18da8e9/401_2025_2862_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/b7b61b5d41f9/401_2025_2862_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/2f6a40da4e1f/401_2025_2862_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/097069ab5f7b/401_2025_2862_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/001a88acc161/401_2025_2862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/e4993d45a700/401_2025_2862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/e78943d45336/401_2025_2862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/9038d1164e5f/401_2025_2862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/d3205b4f0a7c/401_2025_2862_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/caea7de55613/401_2025_2862_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/2ed3c8bbd938/401_2025_2862_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/9c969ae7c589/401_2025_2862_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/a6fe3d6d2371/401_2025_2862_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/a31447a93c13/401_2025_2862_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/3d05f18da8e9/401_2025_2862_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/b7b61b5d41f9/401_2025_2862_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/2f6a40da4e1f/401_2025_2862_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c0f/12102137/097069ab5f7b/401_2025_2862_Fig14_HTML.jpg

相似文献

1
Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits.无淀粉样β沉积病例海马结构中早期阿尔茨海默病相关tau包涵体的序列和轨迹
Acta Neuropathol. 2025 May 23;149(1):50. doi: 10.1007/s00401-025-02862-x.
2
The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.嗅觉上皮:病理性tau蛋白传播的关键通道及减轻中枢神经系统tau蛋白病的靶点。
Acta Neuropathol. 2025 Jun 19;149(1):64. doi: 10.1007/s00401-025-02902-6.
3
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.早期 CA2 tau 包含物不能区分与年龄相关的 tau 病与早期阿尔茨海默病。
J Alzheimers Dis. 2024;101(4):1333-1353. doi: 10.3233/JAD-240483.
4
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.神经退行性疾病死后视网膜的神经病理学特征。
Acta Neuropathol. 2024 Aug 19;148(1):24. doi: 10.1007/s00401-024-02769-z.
5
Immunoelectron microscopy and biochemical studies using three anti-tau antibodies in human brains: associations between pTau and ribosomes.使用三种抗tau抗体对人脑进行免疫电子显微镜和生化研究:pTau与核糖体之间的关联
Acta Neuropathol Commun. 2025 Jul 7;13(1):150. doi: 10.1186/s40478-025-02072-2.
6
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
7
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.与 APP 双突变和唐氏综合征家族性阿尔茨海默病相关的脑淀粉样血管病的淀粉样-β肽特征。
Acta Neuropathol. 2024 Jul 18;148(1):8. doi: 10.1007/s00401-024-02756-4.
8
Assessing Co-Localization of ITM2B With Alzheimer's Disease and Limbic-Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.评估ITM2B与阿尔茨海默病以及边缘叶为主的年龄相关性TDP-43脑病神经病理变化的共定位情况。
Neuropathology. 2025 Aug;45(4):e70003. doi: 10.1111/neup.70003. Epub 2025 Mar 5.
9
Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4.阿尔茨海默病及其合并病变:对海马体退化、认知衰退的影响以及载脂蛋白E ε4的作用
Alzheimers Dement. 2025 Jul;21(7):e70483. doi: 10.1002/alz.70483.
10
Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer's disease.增强的小胶质细胞动力学和 Tau 种在淀粉样斑块微环境中的缺乏导致阿尔茨海默病的认知弹性。
Acta Neuropathol. 2024 Aug 5;148(1):15. doi: 10.1007/s00401-024-02775-1.

引用本文的文献

1
Reply: PART and amyloid cascade hypotheses are alive and well (but are not so simple).回复:朊蛋白累积导致神经变性假说和淀粉样蛋白级联假说仍然成立(但并非如此简单)。
Acta Neuropathol. 2025 Aug 6;150(1):15. doi: 10.1007/s00401-025-02921-3.
2
PART and amyloid cascade hypotheses are alive and well (but are not so simple). Scientific commentary on: "Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits".淀粉样蛋白瀑布假说依然活跃且合理(但并非如此简单)。关于“无β淀粉样蛋白沉积病例海马结构中早期阿尔茨海默病相关tau包涵体的序列和轨迹”的科学评论。
Acta Neuropathol. 2025 Aug 6;150(1):14. doi: 10.1007/s00401-025-02920-4.
3

本文引用的文献

1
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.早期 CA2 tau 包含物不能区分与年龄相关的 tau 病与早期阿尔茨海默病。
J Alzheimers Dis. 2024;101(4):1333-1353. doi: 10.3233/JAD-240483.
2
Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early-stage neurodegeneration. aged rhesus macaque 内嗅皮层和背外侧前额叶皮质中 pT217-tau 的纳米级成像:神经元内转运和早期神经退行性变的证据。
Alzheimers Dement. 2024 Apr;20(4):2843-2860. doi: 10.1002/alz.13737. Epub 2024 Mar 6.
3
Immunohistochemical field parcellation of the human hippocampus along its antero-posterior axis.
An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease.
阿尔茨海默病中淀粉样蛋白、tau蛋白和炎症病理生理学之间关系的综合观点。
Alzheimers Dement. 2025 Aug;21(8):e70404. doi: 10.1002/alz.70404.
人类海马体沿前后轴的免疫组织化学领域分区。
Brain Struct Funct. 2024 Mar;229(2):359-385. doi: 10.1007/s00429-023-02725-9. Epub 2024 Jan 5.
4
Biomarker modeling of Alzheimer's disease using PET-based Braak staging.使用基于 PET 的 Braak 分期对阿尔茨海默病的生物标志物建模。
Nat Aging. 2022 Jun;2(6):526-535. doi: 10.1038/s43587-022-00204-0. Epub 2022 Apr 25.
5
Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease.寡聚化、磷酸化和截断的 tau 以及剪接体病理学在阿尔茨海默病各阶段的内嗅-海马连接组内。
J Comp Neurol. 2023 Dec;531(18):2080-2108. doi: 10.1002/cne.25466. Epub 2023 Mar 29.
6
Hypothesis review: Alzheimer's overture guidelines.假设性综述:阿尔茨海默病前期指南
Brain Pathol. 2023 Jan;33(1):e13122. doi: 10.1111/bpa.13122. Epub 2022 Oct 12.
7
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease.髓鞘水平越高,阿尔茨海默病中对 tau 病理学的抵抗力就越强。
Alzheimers Res Ther. 2022 Sep 24;14(1):139. doi: 10.1186/s13195-022-01074-9.
8
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies.重新审视 Tau 蛋白聚集与病理形成的机制:脑病理学的新见解如何塑造我们对 Tau 蛋白病的研究及靶向治疗方法。
Chem Soc Rev. 2022 Jan 24;51(2):513-565. doi: 10.1039/d1cs00127b.
9
The many dimensions of human hippocampal organization and (dys)function.人类海马体组织和(功能)障碍的多维度研究。
Trends Neurosci. 2021 Dec;44(12):977-989. doi: 10.1016/j.tins.2021.10.003. Epub 2021 Oct 27.
10
In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline.体内和神经病理学数据支持蓝斑核完整性作为阿尔茨海默病病理学和认知衰退的指标。
Sci Transl Med. 2021 Sep 22;13(612):eabj2511. doi: 10.1126/scitranslmed.abj2511.